ArticleDiabetologia2013

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.

A M D Watson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.